Provided by Tiger Trade Technology Pte. Ltd.

Entrada Therapeutics, Inc.

7.62
+0.29003.96%
Post-market: 7.620.00000.00%19:30 EDT
Volume:269.98K
Turnover:2.04M
Market Cap:295.81M
PE:-1.92
High:7.67
Open:7.39
Low:7.39
Close:7.33
52wk High:16.45
52wk Low:5.02
Shares:38.82M
Float Shares:26.88M
Volume Ratio:1.43
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9676
EPS(LYR):-3.4746
ROE:-54.09%
ROA:-29.20%
PB:1.27
PE(LYR):-2.19

Loading ...

Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2026

Major Issues Report

Form 8-K - Current report
Jul 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 11, 2026

Major Issues Report

Form 8-K - Current report
May 19, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Jan 08, 2026

Major Issues Report

Form 8-K - Current report
Dec 01, 2025

Correspondence

Form CORRESP - Correspondence
Nov 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities